PARP

1
GR PARP GAPDH Dex Treatment - + - + Antagomir Control miR-130b S4. MM.1Re cells were transfected with either control or anti-miR-130b antagomirs (10nM) for 24hrs then treated with 1μM Dex for an additional 48hrs. A. Whole cell lysates were then collected and analyzed by immunblot. B. Total RNA was collected and miR-130b expression levels measured. m iR-130b R elative E xpression 0 0.2 0.4 0.6 0.8 1 1.2 M M .1Re C ont M M .1R e C ontDex M M .1Re anti-130b M M .1Re anti-130b D ex C ellLine and Antagom ir RelativeQuantity A B

description

A. B. Antagomir Control miR-130b. Dex Treatment - + - +. GR. PARP. GAPDH. - PowerPoint PPT Presentation

Transcript of PARP

Page 1: PARP

GR

PARP

GAPDH

Dex Treatment - + - +

Antagomir Control miR-130b

S4. MM.1Re cells were transfected with either control or anti-miR-130b antagomirs (10nM) for 24hrs then treated with 1μM Dex for an additional 48hrs. A. Whole cell lysates were then collected and analyzed by immunblot. B. Total RNA was collected and miR-130b expression levels measured.

miR-130b Relative Expression

0

0.2

0.4

0.6

0.8

1

1.2

MM.1Re Cont MM.1Re Cont Dex MM.1Re anti-130b MM.1Re anti-130bDex

Cell Line and Antagomir

Rela

tive

Qua

ntity

A B